O clickbait no ciberjornalismo português e brasileiro: o caso brasileiro

O trabalho tem como proposta analisar a incidência de "clickbait" no jornalismo online português e brasileiro. Faz parte de uma atividade realizada em conjunto por pesquisadores brasileiros e portugueses, em que cada grupo efetuou a verificação em 18 veículos de informação geral do seu país com abrangência nacional, com produção própria e atualizada frequentemente, tanto nas páginas Web, assim como no Facebook. Este artigo traz os resultados encontrados na amostra brasileira que apontam um alto índice de "clickbait" ao se verificar os dados gerais, com 54,4% da amostra com ocorrência desta prática. Ao mesmo tempo, os valores se reduzem ao olharmos os 32 indicadores individualmente, em que apenas três tiveram índices superiores a 10%.The paper aims to analyze the incidence of clickbait in Portuguese and Brazilian online journalism. It is part of an activity carried out jointly by Brazilian and Portuguese researchers, in which each group carried out the verification in the Web and Facebook pages of 18 general information vehicles of such countries, each having national coverage, as well as its own production and frequent updates. This article presents the results found in the Brazilian sample that shows a high clickbait index, of 54.4%, when crosschecking the general data. On the other hand, the values are reduced when we look at the 32 indicators individually, in which only three had rates above 10%

O clickbait no ciberjornalismo português e brasileiro: o caso português

A investigação que aqui se apresenta partiu da proposta de analisar a incidência de clickbait no ciberjornalismo português e brasileiro. Faz parte de um projeto desenvolvido em conjunto por investigadores brasileiros e portugueses, em que cada grupo efetuou a verificação em 18 cibermeios de informação geral do seu país com abrangência nacional e com produção própria e atualizada frequentemente, tanto nas páginas Web como no Facebook. Neste artigo apresentamos os resultados encontrados nos 270 títulos/conteúdos que constituíram a amostra portuguesa, que apontam para um índice de clickbait de 39,6%. Analisando individualmente os 32 indicadores, verificamos que nenhum chega aos 10%, destacando-se como valor mais alto a "Informação empolada", presente em 8,5% da amostra.The paper aims to analyze the incidence of clickbait in Portuguese and Brazilian online journalism. It is part of an activity carried out jointly by Brazilian and Portuguese researchers, in which each group carried out the verification in the Web and Facebook pages of 18 general information vehicles of such countries, each having national coverage, as well as its own production and frequent updates. This article presents the results found in the Portuguese sample that shows a high clickbait index, of 39,6%, when cross-checking the general data. On the other hand, the values are reduced when we look at the 32 indicators individually, all of them with rates below 10%

Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3

BACKGROUND: Pegylated interferon (Peg-IFN) and standard interferon (IFN) play a significant role in the treatment of hepatitis C virus (HCV) infection. Biosimilar standard IFN is widely available in Brazil for the treatment of HCV infection genotypes 2 or 3, but its efficacy compared to Peg-IFN is unknown. OBJECTIVE: To compare the sustained virological response (SVR) rates following treatment with biosimilar standard IFN plus ribavirin (RBV) versus Peg-IFN plus RBV in patients with HCV genotypes 2 or 3 infection. METHODS: A retrospective cohort study was conducted in patients with HCV genotypes 2 or 3 infection treated with biosimilar standard IFN plus RBV or with Peg-IFN plus RBV. SVR rates of the two treatments were compared. RESULTS: From January 2005 to December 2010, 172 patients with a mean age of 44 +/- 9.3 years were included. There were eight (4.7%) patients with HCV genotype 2 infections. One hundred fourteen (66.3%) were treated with biosimilar standard IFN plus RBV, whist 58 (33.7%) patients were treated with Peg-IFN plus RBV. Between the two groups, there were no significant differences regarding age, gender, glucose level, platelet count, hepatic necroinflammatory grade, and hepatic fibrosis stage. Overall, 59.3% (102/172) patients had SVR. In patients treated with Peg-IFN plus RBV, 79.3% (46/58) had SVR compared to 49.1% (56/114) among those treated with biosimilar standard IFN plus RBV (p = 0.0001). CONCLUSION: In patients with HCV genotypes 2 or 3 infection, a higher SVR was observed in patients receiving Peg-IFN plus RBV related to patients treated with biosimilar standard IFN plus RBV

Therapeutic Effectiveness Of Biosimilar Standard Interferon Versus Pegylated Interferon For Chronic Hepatitis C Genotypes 2 Or 3.

Pegylated interferon (Peg-IFN) and standard interferon (IFN) play a significant role in the treatment of hepatitis C virus (HCV) infection. Biosimilar standard IFN is widely available in Brazil for the treatment of HCV infection genotypes 2 or 3, but its efficacy compared to Peg-IFN is unknown. To compare the sustained virological response (SVR) rates following treatment with biosimilar standard IFN plus ribavirin (RBV) versus Peg-IFN plus RBV in patients with HCV genotypes 2 or 3 infection. A retrospective cohort study was conducted in patients with HCV genotypes 2 or 3 infection treated with biosimilar standard IFN plus RBV or with Peg-IFN plus RBV. SVR rates of the two treatments were compared. From January 2005 to December 2010, 172 patients with a mean age of 44 +/- 9.3 years were included. There were eight (4.7%) patients with HCV genotype 2 infections. One hundred fourteen (66.3%) were treated with biosimilar standard IFN plus RBV, whist 58 (33.7%) patients were treated with Peg-IFN plus RBV. Between the two groups, there were no significant differences regarding age, gender, glucose level, platelet count, hepatic necroinflammatory grade, and hepatic fibrosis stage. Overall, 59.3% (102/172) patients had SVR. In patients treated with Peg-IFN plus RBV, 79.3% (46/58) had SVR compared to 49.1% (56/114) among those treated with biosimilar standard IFN plus RBV (p = 0.0001). In patients with HCV genotypes 2 or 3 infection, a higher SVR was observed in patients receiving Peg-IFN plus RBV related to patients treated with biosimilar standard IFN plus RBV.16232-

A viagem científica de Neiva e Penna: roteiro para os estudos das doenças do sertão The scientific journey taken by Neiva and Penna: a blueprint for studies of diseases from the Brazilian hinterland

Analisa o relatório de Arthur Neiva e Belisario Penna , focalizando a contribuição dos autores ao estudo de uma das doenças endêmicas por eles encontrada ao longo de todo o trajeto percorrido, de longa data conhecida popularmente por 'mal de engasgo'. Observaram e descreveram com minúcia os sintomas apresentados pelos doentes e a associação frequente do mal de engasgo com outro mal endêmico conhecido por 'vexame' ou 'vexame do coração', que consistia em crises de palpitações. Os estudos epidemiológicos e clínicos de Neiva e Penna sobre o mal de engasgo muito contribuíram para o conhecimento dessa afecção e representaram um incentivo para todos os pesquisadores que se dedicaram ao seu estudo, especialmente quanto a sua relação com a doença de Chagas.<br>Analyze the report by Neiva and Penna, focusing on the contribution these authors made to the study of one of the endemic diseases encountered throughout their journey, which had been long known under the popular name of mal de engasgo (choking disease). They recorded their observations and detailed descriptions of the patients' symptoms and the association frequently encountered between mal de engasgo and another endemic disease, known as vexame or vexame do coração, characterized by bouts of palpitations. Neiva and Penna's epidemiological and clinical observations of mal de engasgo were crucial for all the researchers interested in the disease, especially its relationship with Chagas disease